News
Step into the World of QT BIO
Literature Sharing: Rapid detection of Ebolavirus using isothermal recombinase-aided amplification
Release date:
2025-10-29
In September of this year, the WHO received an alert from the Ministry of Health of the Democratic Republic of the Congo regarding suspected cases of Ebola Virus Disease (EVD). EVD is a highly fatal infectious disease. Although vaccines have become available, rapid case identification remains crucial for outbreak control, creating a persistent and urgent need for rapid diagnostic methods. Notably, as early as 2024, researchers had already developed an effective solution. The literature shared today introduces a diagnostic method suitable for field detection utilizing Recombinase-Aided Amplification (RAA) technology, which can deliver results within 15 minutes.
Source: https://doi.org/10.1002/jmv.29744
In September of this year, the WHO received an alert from the Ministry of Health of the Democratic Republic of the Congo regarding suspected cases of Ebola Virus Disease (EVD). EVD is a highly fatal infectious disease. Although vaccines have become available, rapid case identification remains crucial for outbreak control, creating a persistent and urgent need for rapid diagnostic methods. Notably, as early as 2024, researchers had already developed an effective solution. The literature shared today introduces a diagnostic method suitable for field detection utilizing Recombinase-Aided Amplification (RAA) technology, which can deliver results within 15 minutes.
I. Research Background & Current Problem
Currently, Ebola diagnosis primarily relies on real-time reverse transcription polymerase chain reaction (RT-PCR). While this method is sensitive and specific, it requires specialized laboratories and equipment, is time-consuming (taking hours to days), and is difficult to deploy in resource-limited areas. In contrast, rapid antigen/antibody tests are simple to operate but often suffer from lower sensitivity and a higher risk of false positives. Therefore, this study aimed to evaluate an isothermal detection technology called RAA as a faster, simpler, molecular detection method applicable for field use.
II. Research Methods & Key Findings
Technical Principle:
Reverse Transcription RAA (RT-RAA) is an isothermal nucleic acid amplification technology. The RAA is a variation of RPA in which Escherichia coli SSB replaces T4 phage GP32 as the single‐strand binding protein. This technique operates at a constant temperature (42°C), is fast (completed within 15 minutes), and has low equipment requirements, making it more suitable for rapid field testing.
Primer/Probe Design:
Researchers evaluated six primer sets and one probe. The primer/probe combination named "EBOO" was selected for subsequent validation because it demonstrated the shortest time to threshold (Tt) and the highest fluorescence signal (mV) during testing.
Sensitivity:
The limit of detection (LoD) for this EBOO RT-RAA assay was 22.6 virus molecular copies per microliter, indicating high sensitivity.
Specificity:
The assay showed no cross-reactivity with 11 other pathogens that can cause similar symptoms, including Dengue virus, Yellow fever virus, Marburg virus, and Lassa virus, demonstrating excellent specificity.
Clinical Validation:
A blind test was conducted using 40 archived clinical samples from the 2014-2016 West Africa Ebola outbreak. The results showed 100% concordance between the RT-RAA assay and the standard RT-PCR method (20 positive and 20 negative samples), achieving 100% clinical sensitivity and specificity.
III. Research Significance & Value
1. Addressing Supply Chain Issues: An important context for this study was the supply shortage faced by kits for the previously widely used RPA technology. This study successfully validated the reliability of the alternative RAA kit, ensuring the sustainable application of this rapid detection technology.
2. Addressing Limitations of Existing Technologies: The developed RT-RAA assay effectively addresses the limitations of current methods: it overcomes the dependency of RT-PCR on specialized personnel and time, while its molecular nature solves the issue of high false-positive rates associated with antigen tests.
3. Exceptional Potential for Field Application: This technology is fast (results in 15 minutes), highly sensitive, and specific, making it highly suitable for deployment in remote areas lacking advanced laboratory facilities, at border ports, or in mobile laboratories (e.g., "suitcase labs") to achieve ultra-rapid "sample-to-result" diagnosis.
IV. Summary
This study successfully developed and validated a rapid molecular detection method for Ebolavirus based on RT-RAA technology. The assay demonstrates excellent performance, comparable to the laboratory "gold standard" RT-PCR. As the author states, this rapid isothermal RT-RAA detection method can replace the previous RT-RPA technology, providing a continuous rapid diagnostic solution for Ebolavirus. Simultaneously, it possesses the advantages of speed, simplicity, and stability required for point-of-care testing, offering a powerful new diagnostic tool for future responses to Ebola outbreaks.
Previous page
Previous page:
Product Inquiry
Product inquiries: 0510-85385531
Technical Support: 18921157475
Corporate email: qt@qt-bio.com
Company Address: Building B, Floors 4-5, Xingye Building, No. 97 Linghu Avenue, Xinwu District, Wuxi City
Customer service WeChat ID
Official Official Account
www.300.cn